Dietary supplement containing ED drug is recalled voluntarily
Cosmos Trading, Inc., is conducting a voluntary nationwide recall of its dietary supplement product sold under the name Rhino Max (Rhino V Max) after lab analysis found that the product contains aminotadalafil, an analogue of tadalafil, making Rhino Max (Rhino V Max) an unapproved drug.
Cosmos Trading, Inc., is conducting a voluntary nationwide recall of its dietary supplement product sold under the name Rhino Max (Rhino V Max) after lab analysis found that the product contains aminotadalafil, an analogue of tadalafil, making Rhino Max (Rhino V Max) an unapproved drug.
FDA advised that aminotadalafil may interact with nitrates found in prescription drugs for diabetes, hypertension, hyperlipidemia, and cardiovascular disease, and that it may lower blood pressure to dangerous levels. Men who have these medical conditions often have erectile dysfunction, and may ingest products such as Rhino Max to enhance sexual performance.
The current product label does not warn consumers who have high blood pressure not to ingest the product, and it does list aminotadalafil among active ingredients.
IC/BPS has more than 1 phenotype: A need for consensus to move forward
September 19th 2024"A global consensus on standardization of terminology, separation of LUTS vs pain for outcome, HL positivity and negativity, markers for disease, and the role of new interventions for local vs systemic therapy is needed," writes Gopal H. Badlani, MD.
